Late stage talks to buy Springworks Therapeutics for $47/shr
• Mkt Cap $3.525bn at $47/shr. EV $3.1bn.
• EBITDA currently negative and Free Cash Flow negative $180m
• Leverage would increase by <0.5x
Find more articles and bullets on these widgets:
EURGBP is trading lower this week as the cross extends the bear cycle that started Mar 11. The cross has recently breached 0.8369, the Mar 14 low, and has confirmed a clear break of the 50-day EMA, at 0.8351. The average marked a key short-term pivot level and the breach signals scope for a deeper retracement towards 0.8321, a Fibonacci retracement. Initial resistance to watch is 0.8395, the Mar 24 high.
The latest recovery in Schatz futures appears corrective and the trend condition remains bearish. The move higher has allowed an oversold trend reading to unwind. Resistance to watch is 106.847, a Fibonacci retracement. Recent weakness resulted in a breach of key support at 106.735, the Feb 19 low. The break strengthens a bearish theme and signals scope for a deeper sell-off, towards 106.350, a Fibonacci retracement.
The trend structure in GBPUSD remains bullish and the latest shallow pullback appears corrective. Moving average studies are in a bull-mode position and this highlights a dominant uptrend. A resumption of gains would pave the way for a climb towards 1.3048, the Nov 6 2024 high. Initial firm support to watch is 1.2869, the 20-day EMA. Clearance of this level would signal scope for a deeper retracement towards the 50-day EMA, at 1.2731.